Biotech Startups
9,603 companies tagged Biotech, with their investors and founders.
RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases. Its pipeline includes ozureprubart, a long-acting anti-IgE antibody being developed for food allergy.
4 investors
RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.
4 investors
Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
4 investors
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer. It targets both companion animals (particularly dogs) and humans.
4 investors
Relation is an end-to-end biotech company that combines single-cell multi-omics from patient tissue, functional assays, and machine learning to identify druggable targets and develop therapies for serious diseases. Its "Lab-in-the-Loop" platform integrates single-cell analysis, genomics, and machine learning to drive disease understanding from cause to cure.
4 investors
Remix Therapeutics develops RNA reprogramming technology to treat various diseases and disorders. The company applies precision medicine approaches across oncology and other therapeutic areas.
4 investors
Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories. The platform structures experimental results and surfaces insights to help lab teams accelerate research and product development.
4 investors
Resurrect Bio develops genetic disease-resistance traits for crops by restoring plant R-genes, using its FloraFold AI platform and rapid in-planta screening for trait discovery. The company targets agriculture, offering genetic resistance to pathogens and pests as an alternative to chemical fungicides and pesticides.
4 investors
Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.
4 investors
RhyGaze develops gene therapies using optogenetic proteins to restore sight in patients with vision loss caused by retinal photoreceptor dysfunction. The company combines optogenetic technology with gene therapy delivery methods to enable light detection in degenerative eye conditions.
4 investors
Rhythm Pharmaceuticals is a biopharmaceutical company that develops precision medicines and treatment options for patients with rare neuroendocrine diseases, including hyperphagia and obesity. It focuses on therapies addressing the root cause of these conditions for patients, families, and healthcare providers.
4 investors
Sagimet is a clinical-stage biopharmaceutical company developing therapies targeting fatty acid synthase (FASN) for metabolic diseases and oncology. The company advances drug candidates through clinical trials in areas such as metabolic disease.
4 investors
Sangamo is a genomic medicine company using its proprietary zinc finger technology to develop gene therapies aimed at curing severe diseases, with a focus on neurology and rare disorders. Its pipeline covers indications such as small fiber neuropathy, prion disease, Fabry disease, and hemophilia A, including programs partnered with pharmaceutical companies.
4 investors
CSL is a biotechnology company that develops and manufactures plasma-derived and other therapies, including biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and kidney disease. It operates through its CSL Behring, CSL Plasma, CSL Seqirus, and CSL Vifor businesses.
4 investors
Scioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana. This page describes its office locations and employee benefits rather than detailing its products.
4 investors
Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals. The company was acquired by animal health firm Ceva in early 2024, and its work now operates as Ceva's biotechnology campus in Philadelphia.
4 investors
SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery. The device integrates with existing hemodialysis delivery systems and is aimed at reducing dependency on dialysis and time in the ICU.
4 investors
Septerna develops oral small molecule drug candidates targeting G protein-coupled receptors (GPCRs) using its proprietary Native Complex Platform. The company's pipeline focuses on endocrinology, immunology and inflammation, and metabolic diseases for patients with unmet medical needs.
4 investors
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure. It is a publicly listed medical device company addressing unmet needs in the management of ascites and related conditions.
4 investors
Serna builds a platform to unlock the transcriptome as a drug target for drug discovery. The company integrates technology and biology to change drug discovery processes.
4 investors
Shiok Meats grows shrimp and other seafood through cellular agriculture, cultivating animal tissue in laboratories rather than harvesting from wild or farmed sources. The company produces meat with comparable taste, texture, and nutritional content to conventional seafood without animal farming.
4 investors
4 investors
Singular Genomics develops spatial pathology technology to map molecules and cells directly in tissue for disease characterization. The company serves researchers and pathologists in biomedical research and diagnostics.
4 investors
SOLASTA Bio develops peptide-based, precision-targeted biological insecticides that control specific pest insects while remaining non-toxic to non-target species such as pollinators, wildlife and humans. Its crop protection solutions are aimed at growers and agri-businesses as a biodegradable alternative to traditional chemical insecticides.
4 investors